Skip to main content
SpringerLink
Log in

Introduction to In Vivo Cell Reprogramming Technology

  • Chapter
  • First Online:
In Vivo Reprogramming in Regenerative Medicine

Part of the book series: Stem Cell Biology and Regenerative Medicine ((STEMCELL))

  • 491 Accesses

Abstract

Regenerative medicine is an emerging interdisciplinary field which involves the regeneration of the damaged or diseased cells, tissues or organs in order to restore the normal biological function. There has been significant improvements in the development of cell based therapies; however, current treatment strategies still suffer from some problems: the need for long in vitro culture conditions, inefficient delivery of cells by scaffolds and low incorporation and grafting efficiencies. Therefore, in vivo reprogramming has emerged as a novel treatment technology. In the process of in vivo reprogramming, cells switch to another cell type within the living organism. There are successful studies which make use of this technology and hence offer therapeutic options for various organs or tissues.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 109.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Chen L, Tredget EE, Liu C, Wu Y. Analysis of allogenicity of mesenchymal stem cells in engraftment and wound healing in mice. PLoS One. 2009;4(9):e7119. doi:10.1371/journal.pone.0007119.

    Article  PubMed  PubMed Central  Google Scholar 

  2. Mallick KK, Cox SC. Biomaterial scaffolds for tissue engineering. Front Biosci (Elite Ed). 2013;5:341–60. doi:10.2741/e620.

    Article  Google Scholar 

  3. Ilic D, Polak JM. Stem cells in regenerative medicine: introduction. Br Med Bull. 2011;98:117–26. doi:10.1093/bmb/ldr012.

    Article  PubMed  Google Scholar 

  4. Alvarez CV, Garcia-Lavandeira M, Garcia-Rendueles ME, Diaz-Rodriguez E, Garcia-Rendueles AR, Perez-Romero S, Vila TV, Rodrigues JS, Lear PV, Bravo SB. Defining stem cell types: understanding the therapeutic potential of ESCs, ASCs, and iPS cells. J Mol Endocrinol. 2012;49(2):R89–R111. doi:10.1530/JME-12-0072.

    Article  CAS  PubMed  Google Scholar 

  5. Xue L, Xu YB, Xie JL, Tang JM, Shu B, Chen L, Qi SH, Liu XS. Effects of human bone marrow mesenchymal stem cells on burn injury healing in a mouse model. Int J Clin Exp Pathol. 2013;6(7):1327–36.

    PubMed  PubMed Central  Google Scholar 

  6. Gurdon JB. The developmental capacity of nuclei taken from intestinal epithelium cells of feeding tadpoles. J Embryol Exp Morphol. 1962;10(4):622–40.

    CAS  PubMed  Google Scholar 

  7. Takahashi K, Yamanaka S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell. 2006;126(4):663–76. doi:10.1016/j.cell.2006.07.024.

    Article  CAS  PubMed  Google Scholar 

  8. Zhou Q, Brown J, Kanarek A, Rajagopal J, Melton DA. In vivo reprogramming of adult pancreatic exocrine cells to [bgr]-cells. Nature. 2008;455(7213):627–32.

    Article  CAS  PubMed  Google Scholar 

  9. Inagawa K, Miyamoto K, Yamakawa H, Muraoka N, Sadahiro T, Umei T, Wada R, Katsumata Y, Kaneda R, Nakade K, Kurihara C, Obata Y, Miyake K, Fukuda K, Ieda M. Induction of cardiomyocyte-like cells in infarct hearts by gene transfer of Gata4, Mef2c, and Tbx5. Circ Res. 2012;111(9):1147–56. doi:10.1161/CIRCRESAHA.112.271148.

    Article  CAS  PubMed  Google Scholar 

  10. Qian L, Huang Y, Spencer CI, Foley A, Vedantham V, Liu L, Conway SJ, Fu J-d, Srivastava D. In vivo reprogramming of murine cardiac fibroblasts into induced cardiomyocytes. Nature. 2012;485(7400):593–8. doi:10.1038/nature11044. http://www.nature.com/nature/journal/v485/n7400/abs/nature11044.html#supplementary-information

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  11. Song K, Nam Y-J, Luo X, Qi X, Tan W, Huang GN, Acharya A, Smith CL, Tallquist MD, Neilson EG, Hill JA, Bassel-Duby R, Olson EN. Heart repair by reprogramming non-myocytes with cardiac transcription factors. Nature. 2012;485(7400):599–604. doi:10.1038/nature11139. http://www.nature.com/nature/journal/v485/n7400/abs/nature11139.html#supplementary-information

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  12. Jayawardena TM, Egemnazarov B, Finch EA, Zhang L, Alan Payne J, Pandya K, Zhang Z, Rosenberg P, Mirotsou M, Dzau VJ. MicroRNA-mediated in vitro and in vivo direct reprogramming of cardiac fibroblasts to cardiomyocytes. Circ Res. 2012;110(11):1465–73. doi:10.1161/CIRCRESAHA.112.269035.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  13. Ruff CA, Wilcox JT, Fehlings MG. Cell-based transplantation strategies to promote plasticity following spinal cord injury. Exp Neurol. 2012;235(1):78–90. doi:10.1016/j.expneurol.2011.02.010.

    Article  PubMed  Google Scholar 

  14. Tetzlaff W, Okon EB, Karimi-Abdolrezaee S, Hill CE, Sparling JS, Plemel JR, Plunet WT, Tsai EC, Baptiste D, Smithson LJ, Kawaja MD, Fehlings MG, Kwon BK. A systematic review of cellular transplantation therapies for spinal cord injury. J Neurotrauma. 2010;28(8):1611–82. doi:10.1089/neu.2009.1177.

    Article  PubMed  Google Scholar 

  15. Su Z, Niu W, Liu M-L, Zou Y, Zhang C-L. In vivo conversion of astrocytes to neurons in the injured adult spinal cord. Nat Commun. 2014;5:3338. doi:10.1038/ncomms4338. http://dharmasastra.live.cf.private.springer.com/articles/ncomms4338#supplementary-information

    PubMed  PubMed Central  Google Scholar 

  16. Wang L-L, Su Z, Tai W, Zou Y, Xu X-M, Zhang C-L. The p53 pathway controls SOX2-mediated reprogramming in the adult mouse spinal cord. Cell Rep. 2016;17(3):891–903. doi:10.1016/j.celrep.2016.09.038.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  17. Gao X, Wang X, Xiong W, Chen J. In vivo reprogramming reactive glia into iPSCs to produce new neurons in the cortex following traumatic brain injury. Sci Rep. 2016;6:22490. doi:10.1038/srep22490. http://dharmasastra.live.cf.private.springer.com/articles/srep22490#supplementary-information

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  18. Cox CS, Hetz RA, Liao GP, Aertker BM, Ewing-Cobbs L, Juranek J, Savitz SI, Jackson ML, Romanowska-Pawliczek AM, Triolo F, Dash PK, Pedroza C, Lee DA, Worth L, Aisiku IP, Choi HA, Holcomb JB, Kitagawa RS. Treatment of severe adult traumatic brain injury using bone marrow mononuclear cells. Stem Cells. 2017;35(4):1065–79. doi:10.1002/stem.2538.

    Article  CAS  PubMed  Google Scholar 

  19. Harting MT, Baumgartner JE, Worth LL, Ewing-Cobbs L, Gee AP, Day M-C, Cox CS. Cell therapies for traumatic brain injury. Neurosurg Focus. 2008;24(0):E18. doi:10.3171/FOC/2008/24/3-4/E17.

    Article  PubMed  PubMed Central  Google Scholar 

  20. Guo Z, Zhang L, Wu Z, Chen Y, Wang F, Chen G. In vivo direct reprogramming of reactive glial cells into functional neurons after brain injury and in an Alzheimer’s disease model. Cell Stem Cell. 2014;14(2):188–202. doi:10.1016/j.stem.2013.12.001.

    Article  CAS  PubMed  Google Scholar 

  21. Heinrich C, Bergami M, Gascón S, Lepier A, Viganò F, Dimou L, Sutor B, Berninger B, Götz M. Sox2 mediated conversion of NG2 glia into induced neurons in the injured adult cerebral cortex. Stem Cell Rep. 2014;3(6):1000–14. doi:10.1016/j.stemcr.2014.10.007.

    Article  CAS  Google Scholar 

  22. Kim JB, Lee H, Araúzo-Bravo MJ, Hwang K, Nam D, Park MR, Zaehres H, Park KI, Lee S-J. Oct4-induced oligodendrocyte progenitor cells enhance functional recovery in spinal cord injury model. EMBO J. 2015;34(23):2971–83. doi:10.15252/embj.201592652.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  23. Niu W, Zang T, Smith Derek K, Vue Tou Y, Zou Y, Bachoo R, Johnson Jane E, Zhang C-L. SOX2 reprograms resident astrocytes into neural progenitors in the adult brain. Stem Cell Rep. 2015;4(5):780–94. doi:10.1016/j.stemcr.2015.03.006.

    Article  CAS  Google Scholar 

  24. Niu W, Zang T, Zou Y, Fang S, Smith DK, Bachoo R, Zhang C-L. In vivo reprogramming of astrocytes to neuroblasts in the adult brain. Nat Cell Biol. 2013;15(10):1164–75. doi:10.1038/ncb2843.

    Article  CAS  PubMed  Google Scholar 

  25. Grande A, Sumiyoshi K, López-Juárez A, Howard J, Sakthivel B, Aronow B, Campbell K, Nakafuku M. Environmental impact on direct neuronal reprogramming in vivo in the adult brain. Nat Commun. 2013;4:2373. doi:10.1038/ncomms3373. http://dharmasastra.live.cf.private.springer.com/articles/ncomms3373#supplementary-information

    Article  PubMed  PubMed Central  Google Scholar 

  26. Torper O, Pfisterer U, Wolf DA, Pereira M, Lau S, Jakobsson J, Björklund A, Grealish S, Parmar M. Generation of induced neurons via direct conversion in vivo. Proc Natl Acad Sci. 2013;110(17):7038–43. doi:10.1073/pnas.1303829110.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  27. Wolters RJ, Braspenning JCC, Wensing M. Impact of primary care on hospital admission rates for diabetes patients: a systematic review. Diabetes Res Clin Pract. 2017;129:182–96. doi:10.1016/j.diabres.2017.05.001.

    Article  CAS  PubMed  Google Scholar 

  28. Adeniyi A, Anjana R, Weber M. Global account of barriers and facilitators of physical activity among patients with diabetes mellitus: a narrative review of the literature. Curr Diabetes Rev. 2016;12(4):440–8.

    Article  PubMed  Google Scholar 

  29. Baeyens L, Lemper M, Leuckx G, De Groef S, Bonfanti P, Stange G, Shemer R, Nord C, Scheel DW, Pan FC, Ahlgren U, Gu G, Stoffers DA, Dor Y, Ferrer J, Gradwohl G, Wright CVE, Van de Casteele M, German MS, Bouwens L, Heimberg H. Transient cytokine treatment induces acinar cell reprogramming and regenerates functional beta cell mass in diabetic mice. Nat Biotechnol. 2014;32(1):76–83. doi:10.1038/nbt.2747. http://www.nature.com/nbt/journal/v32/n1/abs/nbt.2747.html#supplementary-information

    Article  CAS  PubMed  Google Scholar 

  30. Cavelti-Weder C, Li W, Zumsteg A, Stemann-Andersen M, Zhang Y, Yamada T, Wang M, Lu J, Jermendy A, Bee YM, Bonner-Weir S, Weir GC, Zhou Q. Hyperglycaemia attenuates in vivo reprogramming of pancreatic exocrine cells to beta cells in mice. Diabetologia. 2016;59(3):522–32. doi:10.1007/s00125-015-3838-7.

    Article  CAS  PubMed  Google Scholar 

  31. Miyazaki S, Tashiro F, J-i M. Transgenic expression of a single transcription factor Pdx1 induces transdifferentiation of pancreatic acinar cells to endocrine cells in adult mice. PLoS One. 2016;11(8):e0161190. doi:10.1371/journal.pone.0161190.

    Article  PubMed  PubMed Central  Google Scholar 

  32. Banga A, Akinci E, Greder LV, Dutton JR, Slack JMW. In vivo reprogramming of Sox9+ cells in the liver to insulin-secreting ducts. Proc Natl Acad Sci U S A. 2012;109(38):15336–41. doi:10.1073/pnas.1201701109.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  33. Rezvani M, Español-Suñer R, Malato Y, Dumont L, Grimm Andrew A, Kienle E, Bindman Julia G, Wiedtke E, Hsu Bernadette Y, Naqvi Syed J, Schwabe Robert F, Corvera Carlos U, Grimm D, Willenbring H. In vivo hepatic reprogramming of myofibroblasts with AAV vectors as a therapeutic strategy for liver fibrosis. Cell Stem Cell. 2016;18(6):809–16. doi:10.1016/j.stem.2016.05.005.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  34. Song G, Pacher M, Balakrishnan A, Yuan Q, Tsay H-C, Yang D, Reetz J, Brandes S, Dai Z, Pützer Brigitte M, Araúzo-Bravo Marcos J, Steinemann D, Luedde T, Schwabe Robert F, Manns Michael P, Schöler Hans R, Schambach A, Cantz T, Ott M, Sharma Amar D. Direct reprogramming of hepatic myofibroblasts into hepatocytes in vivo attenuates liver fibrosis. Cell Stem Cell. 2016;18(6):797–808. doi:10.1016/j.stem.2016.01.010.

    Article  CAS  PubMed  Google Scholar 

  35. Yilmazer A, de Lázaro I, Bussy C, Kostarelos K. In vivo cell reprogramming towards pluripotency by virus-free overexpression of defined factors. PLoS One. 2013;8(1):e54754. doi:10.1371/journal.pone.0054754.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  36. Yechoor V, Liu V, Espiritu C, Paul A, Oka K, Kojima H, Chan L. Neurogenin3 is sufficient for transdetermination of hepatic progenitor cells into neo-islets in vivo but not transdifferentiation of hepatocytes. Dev Cell. 2009;16(3):358–73. doi:10.1016/j.devcel.2009.01.012.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  37. Jayawardena TM, Finch EA, Zhang L, Zhang H, Hodgkinson CP, Pratt RE, Rosenberg PB, Mirotsou M, Dzau VJ. MicroRNA induced cardiac reprogramming in vivo evidence for mature cardiac myocytes and improved cardiac function. Circ Res. 2015;116(3):418–24. doi:10.1161/CIRCRESAHA.116.304510.

    Article  CAS  PubMed  Google Scholar 

  38. Murry CE, Kay MA, Bartosek T, Hauschka SD, Schwartz SM. Muscle differentiation during repair of myocardial necrosis in rats via gene transfer with MyoD. J Clin Investig. 1996;98(10):2209–17. doi:10.1172/JCI119030.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  39. Hu Y-F, Dawkins JF, Cho HC, Marbán E, Cingolani E. Biological pacemaker created by minimally invasive somatic reprogramming in pigs with complete heart block. Sci Transl Med. 2014;6(245):245ra294. doi:10.1126/scitranslmed.3008681.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Biotechnology Institute, Ankara University, Golbası, Ankara, Turkey

    Cansu Gurcan & Hadiseh Taheri

  2. Biomedical Engineering Department, Engineering Faculty, Ankara University, Golbası, Ankara, Turkey

    Cansu Gurcan & Hadiseh Taheri

  3. Biomedical Engineering Department, Ankara University, Tandogan, Ankara, Turkey

    Açelya Yilmazer

  4. Stem Cell Institute, Ankara University, Balgat, Ankara, Turkey

    Açelya Yilmazer

Authors
  1. Cansu Gurcan
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Hadiseh Taheri
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Açelya Yilmazer
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Açelya Yilmazer .

Editor information

Editors and Affiliations

  1. Biomedical Engineering Department, Ankara University, Tandogan, Ankara, Turkey

    Açelya Yilmazer

Rights and permissions

Reprints and permissions

Copyright information

© 2017 Springer International Publishing AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Gurcan, C., Taheri, H., Yilmazer, A. (2017). Introduction to In Vivo Cell Reprogramming Technology. In: Yilmazer, A. (eds) In Vivo Reprogramming in Regenerative Medicine. Stem Cell Biology and Regenerative Medicine. Humana Press, Cham. https://doi.org/10.1007/978-3-319-65720-2_1

Download citation

Publish with us

Policies and ethics

Search

Navigation